JPMORGAN CHASE & CO - AGILE THERAPEUTICS INC ownership

AGILE THERAPEUTICS INC's ticker is and the CUSIP is 00847L209. A total of 22 filers reported holding AGILE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of AGILE THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$02770.0%0.00%
Q4 2022$0277
+13750.0%
0.00%
Q3 2022$02
-98.8%
0.00%
Q2 2022$01660.00%
Other shareholders
AGILE THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 50,000$11,3500.01%
Virtu Financial LLC 142,696$320.00%
INVESTOR AB 87,754$20,1830.00%
Warberg Asset Management LLC 17,500$3,9730.00%
Advisory Services Network, LLC 81,500$18,5010.00%
ROYAL BANK OF CANADA 36$00.00%
VANGUARD GROUP INC 76,860$17,4470.00%
JANE STREET GROUP, LLC 44,530$10,1080.00%
UBS Group AG 6$10.00%
TWO SIGMA INVESTMENTS, LP 10,364$2,3530.00%
View complete list of AGILE THERAPEUTICS INC shareholders